肾旁腹主动脉瘤开放修复术的持久性:法国五中心回顾性研究
该多中心回顾性研究评估了315例肾旁腹主动脉瘤择期开放修复术患者的围手术期并发症和晚期死亡率,重点关注肾功能。结果显示30天死亡率为0.9%,急性肾损伤发生率为16.8%,5年生存率为71%±5%,5年无慢性肾功能下降率为89%±3%,表明在适合的患者中开放修复术具有可接受的operativ风险且结果持久。
要点
- 择期开放修复肾旁腹主动脉瘤的30天死亡率为0.9%。
- 急性肾损伤发生率为16.8%,术前慢性肾病、糖尿病、高血压和年龄是其预测因素。
- 5年生存率为71%±5%,5年无慢性肾功能下降率为89%±3%。
核心结论
- 在适合的患者中,肾旁腹主动脉瘤开放修复术具有可接受的手术风险,并且在移植血管完整性和肾功能保护方面结果持久。
研究设计与样本
- 肾旁腹主动脉瘤定义为动脉瘤延伸至肾动脉但未累及肾动脉,即瘤颈长度<10 mm。
主要发现
- 315例患者中,男性292例(92.6%),平均年龄68±8岁,73例(23.2%)基线有慢性肾病(估算肾小球滤过率<60 mL/min/1.73 m2)。
- 30天死亡3例(0.9%),急性肾损伤53例(16.8%),9例(2.9%)需要临时透析,1例需要长期透析。
- Kaplan-Meier估计5年生存率为71%±5%,5年无慢性肾功能下降率为89%±3%。
关键数值与推荐
- 肾动脉阻断平均时间24±7分钟(范围10-55分钟),主动脉阻断水平为腹腔干上(11例)、肾动脉上(235例)或肾动脉间(69例)。
- 随访影像学检查采用CT血管造影,290例(92.6%)患者平均随访4.3±2.4年,肾动脉闭塞发生2例(占成像肾动脉的0.7%)。
临床怎么用
- 对于适合的肾旁腹主动脉瘤患者,开放修复术可作为治疗方案,但需注意术前慢性肾病、糖尿病、高血压和年龄对急性肾损伤风险的影响。
- 术后应监测肾功能,尤其是发生急性肾损伤的患者,因其远期慢性肾功能下降风险显著增加。
局限性
- 本研究为回顾性设计,可能存在选择偏倚和信息偏倚。
- 样本来自法国五家学术中心,结果外推需谨慎。
- 随访影像学并非全部患者完成,可能低估远期移植物相关并发症。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: With a focus on renal function, the goal of this multicentre study was to assess peri-operative complications and late mortality of open surgical repair (OSR) of juxtarenal abdominal aortic aneurysms (JRAAA). METHODS: From February 2005 to December 2015, 315 consecutive patients undergoing elective OSR of a JRAAA in five French academic centres were evaluated retrospectively. The definition of JRAAA was an aortic aneurysm extending up to but not involving the renal arteries, i.e., a short neck <10 mm. End points included post-operative death; acute kidney injury (AKI) defined by the RIFLE (Risk, Injury, Failure, Loss of function, End stage renal disease) criteria; and long term follow-up with freedom from chronic renal decline (CRD) and any graft related complications. Factors predictive of renal insufficiency were determined by multivariable analysis. RESULTS: Of 315 patients, 292 (92.6%) were men (mean age 68 ± 8 years), and 73 (23.2%) had baseline chronic kidney disease (CKD) with an estimated glomerular filtration rate of <60 mL/min/1.73 m2. The level of aortic clamping was supracoeliac (n = 11), suprarenal (n = 235), or inter-renal above one renal artery (n = 69). The mean duration of renal artery clamping was 24 ± 7 min (range 10-55 min). Eleven patients (3.5%) presented with a renal artery stenosis that was treated conservatively. Perfusion of the renal arteries with a chilled Ringer's solution was used selectively in seven patients (2.2%). The overall 30 day mortality was 0.9% (three patients). AKI occurred in 53 patients (16.8%). Nine patients (2.9%) required temporary dialysis and one patient required chronic dialysis. Predictors of AKI were pre-existing CKD (odds ratio [OR] 2.25, 95% confidence interval [CI] 1.13-4.48; p = .021], diabetes (OR 3.15, 95% CI 1.48-6.71; p = .003), hypertension (OR 3.38, 95% CI 1.33-8.57; p = .01), and age (OR 1.05, 95% CI 1.01-1.10; p = .014). The level of aortic clamping and duration of renal artery clamping were not associated with an increased risk of AKI. The Kaplan-Meier survival estimate was 71% ± 5% at five years. Predictors of CRD during follow up were AKI (hazard ratio [HR] 15.81, 95% CI 5.26-47.54; p = .001), diabetes (HR 4.56, 95% CI 1.57-13.17; p = .005), and pre-existing CKD (HR 2.93, 95% CI 1.19-7.20; p = .019), with freedom from CRD of 89% ± 3% at five years. Surveillance imaging was obtained by computed tomography angiography in 290 patients (92.6%) at a mean follow up of 4.3 ± 2.4 years. Renal artery occlusion occurred in two patients (0.7% of imaged renal arteries). One patient (1.9%) had an aneurysm of the visceral aorta and eight patients had a descending thoracic aneurysm. CONCLUSIONS: This multicentre study suggests that in fit patients, open JRAAA repair can be performed with acceptable operative risk with durable results in terms of both graft integrity and preservation of renal function.
引用
- Chaufour X, Segal J, Soler R, et al. Editor's Choice - Durability of Open Repair of Juxtarenal Abdominal Aortic Aneurysms: A Multicentre Retrospective Study in Five French Academic Centres. Eur J Vasc Endovasc Surg. 2019. PMID: 31530501. doi:10.1016/j.ejvs.2019.05.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。